Term
|
Definition
Anti-platelet GP IIb/IIIa Receptor - Blocks aggregation
- IND: angioplasty, unstable angina, MI
- no surgery, trauma or bleeding within 6 wks
|
|
|
Term
|
Definition
Trobolytic (tPA) 5 domains 1st generation - plasminogen activator, enzyme
- IND: acute MI, stroke, Pulmonary embolism
2nd gen - retavase, tenecteplase |
|
|
Term
|
Definition
2nd generation Thrombolitic 5 domain Diffuse faster |
|
|
Term
|
Definition
2nd generation Thrombolytic - aa substitutions
- increased specificity
- increased half life
|
|
|
Term
|
Definition
Pegalyated - IND: macular degeneration (wet/age)
- aptamer drug, binds and inactivates ex. VEGF
|
|
|
Term
Peginterferon alfa 2a and 2b Pegasys Peg-Interon |
|
Definition
pegylation - hepatitis C
- once a week dosing
|
|
|
Term
|
Definition
Pegylated - IND: decrease neutropenia from chemotherapy
- decrease clearance rates
|
|
|
Term
|
Definition
Pegylated - acromegaly (excessive growth)
|
|
|
Term
Methoxypolyethyleneglycol epoetin beta Mircera |
|
Definition
Pegylated EPO - IND: anemia of chronic kidney disease
- decreased clearance rates
|
|
|
Term
|
Definition
INSULIN - microparcipitates, releases slowly
- no peak
|
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Aptomer - pegylated 28 mer olgionucleotide
- inject into eye
- IND: age related macular degeneration
- binds to and inactivates extracellular VEGF
|
|
|
Term
Fomivirsen Sodium Vitravene |
|
Definition
Antisense - Olgionuceotide
- Inject into eye
- IND: Cytomegalovirus (SMV) retinitus in HIV
- Blocks synthesis of CMV immediate early protein IE2
Now thought to be interferon inducer |
|
|
Term
|
Definition
Consensus Sequence - IND: treatment of adult hep C patients
- causes flu like symptoms, depression, irritability
|
|
|
Term
|
Definition
1st generation EPO drug - cytokine, stimulates RBC production
- IND: Anemia induced by chemo & AZT therapies, chronic renal failure
- 1st biotech blockbuster,
- abused!
|
|
|
Term
|
Definition
2nd generation EPO (glycosylated) - Sialylated EPO
- IND: anemia, renal failure, chemo
- 3 fold longer half-life b/c of increase Glycosylation
|
|
|
Term
|
Definition
Lysosomal Glycosidase Enzyme - IND: gaucher's Disease TYPE 1
|
|
|
Term
|
Definition
Lysosomal Glycosidase Enzyme |
|
|
Term
|
Definition
Lysosomal Glycosidase Enzyme - Hurler, Scheie & Hurler-Scheie forms of mucopolysaccharidosis I
|
|
|
Term
|
Definition
Lysosomal Glycosidase Enzyme - Maroteaux-Lamy Syndrome or MPS-VI mucopolysaccharidosis
|
|
|
Term
|
Definition
Pseudoantibody - fusion protein of TNF-alfa receptor + IgG1Fc
- IND: symp of ankylosing spondylitis; plaque psoriasis; psoriatic arthritis; rheumatoid arthritis
- Contraindication: serious infection or sepsis
|
|
|
Term
|
Definition
Pseudoantibody CD-2 receptor |
|
|
Term
|
Definition
Pseudoantibody T-cell Antigen 4 site |
|
|
Term
Gemtuzamab Ozogamicin Mylortag |
|
Definition
Immunotoxin - CD-33 humanized monoantibody + calicheamin
- IND: acute myloid leukemia
- Calicheamicin far to toxic to be used in therapy alone
|
|
|
Term
|
Definition
Fusion Toxin - A/B Diptheria Toxin to IL-2 fragment
- IND: CD-25+ T-Cell lymphoma
- orphan drug, very expensive
|
|
|
Term
|
Definition
Cell Therapy - Stem cell concentrator
- IND: bone marrow transplants
|
|
|
Term
|
Definition
Cell Therapy - increase Condrocytes
- IND: Repair traumatic knee damage
|
|
|
Term
|
Definition
Cell Therapy - Skin construct
- IND: venous leg ulcers
- Diabetes patients
|
|
|
Term
Somatropin Genotropin, Nutropin, Humatrope |
|
Definition
Growth Hormones Ecoli Derived Growth Hormone |
|
|
Term
|
Definition
Growth Hormone Methionyl Growth Hormone |
|
|
Term
Somatropin Saizen, Serostim, Zorbative |
|
Definition
|
|